ZEA Biosciences, a Boston-based brand, is dedicated to growing access to reliable medicines for healthier communities. Their plant biotechnology platform focuses on identifying, producing, and growing high-potency drugs, aiming to unlock more molecules for medicine than ever before. With a mission to validate and grow drugs using plant-based systems, ZEA has already grown 263 plant species that show potential in treating nearly 1,000 diseases worldwide.

Led by founder Jim Wilson, whose passion for growing things and taking a top-down approach has paved the way for this innovative brand, ZEA started in the food industry before pivoting to pharmaceuticals. Leveraging their expertise in precision growing, ZEA's technology platform enables them to identify, test, and trial molecules and their reproduction inside plants, similar to a bioreactor. With their visionary approach and a strong network of key partners supporting them, ZEA Biosciences is becoming a beacon of hope in the field of plant biologics